4DMedical Ltd.ASX: 4DX

4DMedical gains regulatory approval for CT LVAS in Canada

· Issued by 4DMedical Ltd.

Filed with ASX · · 3 pages · English

Summary by 6ix AI

4DMedical Ltd. has received regulatory approval for its CT Lung Ventilation Analysis Software in Canada, enhancing its product portfolio in the region. This approval adds to existing Canadian approvals for other respiratory imaging products, increasing access to the Canadian healthcare market. The CT LVAS™ technology allows clinicians to assess lung ventilation using standard CT scans, improving diagnosis and monitoring of lung diseases. The company aims to pursue further regulatory approvals in Canada to enhance respiratory care across North America.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

4DMedical Ltd. on 6ix

In the deck

Story so far

Earlier from 4DMedical

Later from 4DMedical

All 4DMedical news releases